全文获取类型
收费全文 | 677篇 |
免费 | 72篇 |
国内免费 | 1篇 |
出版年
2023年 | 5篇 |
2022年 | 6篇 |
2021年 | 11篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 14篇 |
2017年 | 12篇 |
2016年 | 13篇 |
2015年 | 34篇 |
2014年 | 41篇 |
2013年 | 33篇 |
2012年 | 39篇 |
2011年 | 37篇 |
2010年 | 25篇 |
2009年 | 17篇 |
2008年 | 33篇 |
2007年 | 31篇 |
2006年 | 35篇 |
2005年 | 31篇 |
2004年 | 28篇 |
2003年 | 19篇 |
2002年 | 23篇 |
2001年 | 14篇 |
2000年 | 16篇 |
1999年 | 11篇 |
1998年 | 9篇 |
1997年 | 5篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 5篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 7篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 3篇 |
1983年 | 7篇 |
1981年 | 6篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1975年 | 8篇 |
1974年 | 14篇 |
1973年 | 9篇 |
1972年 | 7篇 |
1971年 | 3篇 |
1970年 | 7篇 |
1968年 | 3篇 |
排序方式: 共有750条查询结果,搜索用时 15 毫秒
741.
742.
743.
744.
Cheng Han Ng Snow Yunni Lin Yip Han Chin Ming Hui Lee Nicholas Syn Xin Lei Goh Jin Hean Koh Jingxuan Quek Darren Jun Hao Tan Shao Feng Mok Eunice Tan Yock Young Dan Nicholas Chew Chin Meng Khoo Mohammad Shadab Siddiqui Mark Muthiah 《Endocrine practice》2022,28(2):223-230
ObjectiveType 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) are closely related, and antidiabetic medications have been shown to be potential therapeutics in NAFLD. Using a network meta-analysis, we sought to examine the effectiveness of antidiabetic agents for the treatment of NAFLD in patients with type 2 diabetes mellitus.MethodsMedline and Embase were searched for randomized controlled trials relating to the use of antidiabetic agents, including sodium-glucose transport protein 2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists, and peroxisome proliferator-activated receptor gamma (PPARγ) agonists, biguanides, sulfonylureas and insulin, on NAFLD in patients with diabetes. The p-score was used as a surrogate marker of effectiveness.ResultsA total of 14 articles were included in the analysis. PPARγ agonists were ranked as the best treatment in steatosis reduction, resulting in the greatest reduction of steatosis. There was statistical significance between PPARγ agonists [mean difference (MD): ?6.02%, confidence interval (CI): ?10.37% to ?1.67%] and SGLT2 inhibitors (MD: ?2.60%, CI: ?4.87% to ?0.33%) compared with standard of care for steatosis reduction. Compared with PPARγ agonists, SGLT2 inhibitors resulted in a statistical significant reduction in fibrosis (MD: ?0.06, CI: ?0.10 to ?0.02). Body mass index reduction was highest in SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists. Additionally, SGLT2 inhibitors were ranked as the best treatment for increasing high-density lipoprotein and reducing low-density lipoprotein.ConclusionGlucagon-like peptide-1 receptor agonists and SGLT2 inhibitors were suitable alternatives for the treatment of NAFLD in those with type 2 diabetes mellitus with a reduction in body mass index, fibrosis, and steatosis. SGLT2 inhibitors also have the added benefit of lipid modulation. 相似文献
745.
Jingxuan Quek Cheng Han Ng Ansel Shao Pin Tang Nicholas Chew Mark Chan Chin Meng Khoo Chen Poh Wei Yip Han Chin Phoebe Tay Grace Lim Darren Jun Hao Tan Wen Hui Lim Kai En Chan Margaret Teng Eunice Tan Nobuharu Tamaki Daniel Q. Huang Mohammad Shadab Siddiqui Mark D. Muthiah 《Endocrine practice》2022,28(7):667-672
ObjectiveThe recent introduction of the term metabolic associated fatty liver disease (MAFLD) sought to reclassify nonalcoholic fatty liver disease (NAFLD). MAFLD is thought to improve the encapsulation of metabolic dysregulation. However, recent evidence has found significant differences between MAFLD and NAFLD, and prevailing knowledge has largely arisen from studies on NAFLD. Hence, we conducted a meta-analysis and systematic review of the outcomes associated with MAFLD.MethodsMEDLINE and Embase databases were searched for articles relating to outcomes in MAFLD. Analysis was conducted in random effects with hazard ratios (HRs) to account for longitudinal risk assessment of mortality and systemic complications.ResultsA total of 554 articles were identified, of which 17 articles were included. MAFLD resulted in an increase in the overall mortality (HR, 1.24; confidence interval [CI], 1.13-1.34), cancer-related mortality (HR, 1.27; CI, 1.01-1.54), and cardiovascular disease mortality (HR, 1.28, 1.03-1.53; P = .04) compared with non-MAFLD. MAFLD also increases the risk of cardiovascular events (HR, 1.49; CI, 1.34-1.64; P < .01), stroke (HR, 1.55; CI, 1.37-1.73; P < .01), and chronic kidney disease (HR, 1.53; CI, 1.38-1.68). The presence of MAFLD was also associated with an increased risk of heart failure, obstructive sleep apnea, and malignancy.ConclusionMAFLD can significantly elevate the risk of systemic diseases and mortality. The care of MAFLD thus requires interdisciplinary collaboration, and future clinical trials conducted on MAFLD should aim to reduce the incidence of end-organ damage aside from improving liver histology. 相似文献
746.
S.G. Cheung P.Y. Tong K.M. Yip P.K.S. Shin 《Marine and Freshwater Behaviour and Physiology》2013,45(2):127-135
Juveniles of the green-lipped mussel Perna viridis (Bivalvia: Mytilidae) were exposed to either chemical cues of damaged conspecifics or predator, including the swimming crab Thalamita danae and the muricid gastropod Thais clavigera. Byssus production was monitored for 48?h but the highest production rate occurred in the first 6?h. Longer and thicker byssal threads with a larger total volume were produced by P. viridis exposed to damaged conspecifics and predators as compared with the control. Numbers of individuals which shed stalks during the experiment varied significantly from 0 to 50%, and with a significantly higher value obtained for the control. Results indicated that byssus production is a plastic response which could be induced by exposure to chemical signals from predators and damaged conspecifics, the latter producing the largest response. Firmer byssal attachment not only reduces predation risk but also non-predation mortality by securing an animal more effectively to its habitat. 相似文献
747.
748.
Shunji Takahashi Wai-Cheung Yip Toshiko Matsugami Goro Tamura 《Journal of plant research》1996,109(4):363-368
The ferredoxin-sulfite reductase (Fd-SiR; hydrogen-sulfide: ferredoxin oxidoreductase, EC 1.8.7.1) activities of shoot and
root of leek (Allium tuberosum) were increased by sulfate limitation in the early stage of growth. Western blot analysis demonstrated an increased amount
of SiRs in root under sulfate limitation, suggesting that SiRs were derepressed. The derepression was observed in shoot when
1.5 mM nitrate was supplied to the plants under sulfate limitation, and clearly in root when 15 mM nitrate was supplied under
sulfate limitation. When nitrate was absent from the nutrient solution, the SiR activity in both tissues was very low. Combined
with the results of the sulfate- or nitrate-limitation experiments, it is suggested that the degree of the derepression of
SiR in both tissue under sulfate limitation is affected by the concentration of nitrate, and further that the mechanism of
regulation of the SiR activity is different in each tissue. The decreases in the ratios of the total SiR activities (shoot/root)
in the latter stage of seedling growth indicate that root play a very important role in sulfate assimilation. 相似文献
749.
Chun-Wah Marcus Yuen Joanne Yip Liwei Liu Kevin Cheuk Chi-Wai Kan Hing-Cheong Cheung Shuk-Yan Cheng 《Carbohydrate polymers》2012,89(3):795-801
In this paper, a simple and versatile coacervation technique has been developed by using an ultrasound-assisted oil/water emulsion method for the preparation of antifungal agent-loaded microcapsules. Two types of chitosan microcapsules are successfully prepared. The mean particle size of the chitosan/miconazole nitrate microcapsules is 2.6 μm and that of the chitosan/clotrimazole microcapsules is 4.1 μm. The encapsulation efficiency of the chitosan/miconazole nitrate microcapsules (77.58–96.81%) is relatively higher than that of the chitosan/clotrimazole microcapsules (56.66–93.82%). The in vitro drug release performance of the microcapsules shows that the chitosan/miconazole nitrate microcapsules release about 49.5% of the drug while chitosan/clotrimazole microcapsules release more than 66.1% of the drug after 12 h under a pressure of 5 kg at pH 5.5, which is similar to the pH of human skin. The prepared drug-loaded microcapsules could be applied onto bandages or socks, and will continuously release antifungal drugs in a controlled manner under pressure. 相似文献
750.
Hon-Kan Yip Kun-Chen Lin Pei-Hsun Sung John Y. Chiang Tsung-Cheng Yin Re-Wen Wu Kuan-Hung Chen 《Journal of cellular and molecular medicine》2021,25(12):5640-5654
This study tested the hypothesis that combined therapy with human umbilical cord-derived mesenchymal stem cells (HUCDMSCs) and hyperbaric oxygen (HBO) was superior to either one on preserving neurological function and reducing brain haemorrhagic volume (BHV) in rat after acute intracerebral haemorrhage (ICH) induced by intracranial injection of collagenase. Adult male SD rats (n = 30) were equally divided into group 1 (sham-operated control), group 2 (ICH), group 3 (ICH +HUCDMSCs/1.2 × 106 cells/intravenous injection at 3h and days 1 and 2 after ICH), group 4 (ICH +HBO/at 3 hours and days 1 and 2 after ICH) and group 5 (ICH +HUCDMSCs-HBO), and killed by day 28 after ICH. By day 1, the neurological function was significantly impaired in groups 2-5 than in group 1 (P < .001), but it did not differ among groups 2 to 5. By days 7, 14 and 28, the integrity of neurological function was highest in group 1, lowest in group 2 and significantly progressively improved from groups 3 to 5 (all P < .001). By day 28, the BHV was lowest in group 1, highest in group 2 and significantly lower in group 5 than in groups 3/4 (all P < .0001). The protein expressions of inflammation (HMGB1/TLR-2/TLR-4/MyD88/TRAF6/p-NF-κB/IFN-γ/IL-1ß/TNF-α), oxidative stress/autophagy (NOX-1/NOX-2/oxidized protein/ratio of LC3B-II/LC3B-I) and apoptosis (cleaved-capspase3/PARP), and cellular expressions of inflammation (CD14+, F4/80+) in brain tissues exhibited an identical pattern, whereas cellular levels of angiogenesis (CD31+/vWF+/small-vessel number) and number of neurons (NeuN+) exhibited an opposite pattern of BHV among the groups (all P < .0001). These results indicate that combined HUCDMSC-HBO therapy offered better outcomes after rat ICH. 相似文献